JPH0419206B2 - - Google Patents
Info
- Publication number
- JPH0419206B2 JPH0419206B2 JP21564683A JP21564683A JPH0419206B2 JP H0419206 B2 JPH0419206 B2 JP H0419206B2 JP 21564683 A JP21564683 A JP 21564683A JP 21564683 A JP21564683 A JP 21564683A JP H0419206 B2 JPH0419206 B2 JP H0419206B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- oral composition
- wasp
- water
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 claims description 22
- 239000012046 mixed solvent Substances 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000000606 toothpaste Substances 0.000 description 9
- 229940034610 toothpaste Drugs 0.000 description 9
- 230000008961 swelling Effects 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 241000264877 Hippospongia communis Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 241000256856 Vespidae Species 0.000 description 4
- 208000007565 gingivitis Diseases 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000034619 Gingival inflammation Diseases 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- -1 etc.) Chemical compound 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 229940105631 nembutal Drugs 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003610 anti-gingivitis Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】
本発明は口腔用組成物、更に詳しくは抗歯肉炎
作用を有する口腔用組成物に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an oral composition, and more particularly to an oral composition having anti-gingivitis activity.
歯肉の炎症は、歯垢中の口腔細菌による作用、
即ち、細菌由来のコラゲナーゼ、プロテアーゼ、
ヒアルロニダーゼ等の歯周組織に対する作用若し
くは細菌由来のアミン、内毒素等の作用等の局所
的な原因、また栄養状態、糖尿病等の全身的な原
因により起ると考えられている。この歯肉炎の予
防、治療を目的として、これまでに、クロルヘキ
シジンに代表される殺菌剤;リゾチーム、アミラ
ーゼ、デキストラナーゼ、ムタナーゼ等の酵素;
ε−アミノカプロン酸、トラネキサム酸等の止血
剤;その他アラントインや食塩等が用いられてき
たが、未だ充分な効果は得られていない。 Gingival inflammation is caused by the effects of oral bacteria in dental plaque.
That is, bacterial-derived collagenase, protease,
It is thought to be caused by local causes such as the action of hyaluronidase on the periodontal tissue or the action of bacterial amines and endotoxins, as well as systemic causes such as nutritional status and diabetes. For the purpose of preventing and treating this gingivitis, disinfectants such as chlorhexidine; enzymes such as lysozyme, amylase, dextranase, and mutanase;
Hemostatic agents such as ε-aminocaproic acid and tranexamic acid; and other agents such as allantoin and salt have been used, but sufficient effects have not yet been obtained.
本発明者は、斯かる現状に鑑み、歯肉の炎症の
軽減、抑制に有効な口腔用組成物を見出すべく鋭
意研究した結果、口腔用組成物に特定の蜂の巣
(露蜂房)の抽出物を配合すれば、歯肉炎の予防、
治療に有効な口腔用組成物が得られることを見出
し本発明を完成した。 In view of the current situation, the present inventor conducted extensive research to find an oral composition that is effective in reducing and suppressing gingival inflammation, and as a result, the inventor of the present invention has formulated an extract of a specific beehive (Ruw beehive) into an oral composition. This will help prevent gingivitis,
The present invention was completed based on the discovery that a therapeutically effective oral composition can be obtained.
すなわち、本発明は、アシナガバチ、スズメバ
チ、クロスズメバチの蜂の巣(露蜂房)の抽出物
を含有する口腔用組成物を提供するものである。 That is, the present invention provides an oral composition containing an extract of honeycombs of paper wasps, wasps, and wasps.
本発明に使用するアシナガバチ、スズメバチ、
クロスズメバチの蜂の巣は、漢方では露蜂房と称
し、鎮痛、消炎、鎮静、解毒、催乳等を目的とし
て用いられるが、蜂の巣の抽出物を歯肉炎の予
防、治療を目的として外用剤に用いられた例はな
く、また口腔用組成物に配合された例もない。 Paper wasp, wasp used in the present invention,
The honeycomb of the black hornet is called dew beehive in Chinese medicine and is used for the purposes of analgesia, anti-inflammation, sedation, detoxification, lactation, etc., and honeycomb extract has been used as an external preparation for the prevention and treatment of gingivitis. There are no examples, and there are no examples of it being incorporated into oral compositions.
該蜂の巣の抽出に用いる溶媒としては、水又は
メタノール、エタノール、アセトン、酢酸エチ
ル、ベンゼン、ヘキサン、石油エーテル等の有機
溶媒が使用される。また、水−アルコール(メタ
ノール、エタノール等)、水−アセトン等の混合
溶媒も使用できる。これらの抽出溶媒の中で、特
に水−エタノール混合溶媒が好ましい。 As the solvent used for extracting the honeycomb, water or an organic solvent such as methanol, ethanol, acetone, ethyl acetate, benzene, hexane, petroleum ether, etc. is used. Further, mixed solvents such as water-alcohol (methanol, ethanol, etc.), water-acetone, etc. can also be used. Among these extraction solvents, a water-ethanol mixed solvent is particularly preferred.
本発明において、有効成分として用いる抽出物
は、該蜂の巣を水、有機溶媒又は水−有機溶媒の
混合溶媒で公知の方法により抽出し、抽出液の不
溶物を除去し、必要に応じて抽出液から溶媒を留
去することにより製造できる。 In the present invention, the extract used as an active ingredient is obtained by extracting the honeycomb with water, an organic solvent, or a mixed solvent of water and an organic solvent by a known method, removing insoluble matter from the extract, and adding the extract as necessary. It can be produced by distilling off the solvent from.
本発明において、該蜂の巣の抽出物の口腔用組
成物中への配合量は、必ずしも制限されないが、
抽出溶媒を留去した残分(エキス)として、全組
成中0.001〜10重量%が好ましく、抗炎症効果や
使用感の点から0.01〜5重量%が特に好ましい。 In the present invention, the amount of the honeycomb extract incorporated into the oral composition is not necessarily limited, but
The residue (extract) after distilling off the extraction solvent is preferably 0.001 to 10% by weight in the total composition, and particularly preferably 0.01 to 5% by weight from the viewpoint of anti-inflammatory effect and feeling of use.
本発明の口腔用組成物には、上記抽出物のほか
に、通常口腔用組成物に使用される成分はいづれ
も添加配合することができる。これらの成分とし
ては、例えば、練歯磨の場合、第二リン酸カルシ
ウム、炭酸カルシウム、水酸化アルミニウム、非
晶質シリカ、結晶質シリカ等の研磨剤;カルボキ
シメチルセルロースナトリウム、カラギーナン、
ヒドロキシエチルセルロース等の粘結剤;ラウリ
ル硫酸ナトリウム、ラウロイルサルコシン酸ナト
リウム、N−アシルグルタミン酸塩、シヨ糖脂肪
酸エステル等の界面活性剤;グリセリン、ソルビ
トール、プロピレングリコール等の湿潤剤が挙げ
られる。また、更に、他の薬効剤を併用すること
もでき、例えば、各種フツ素化合物、アルミニウ
ムアラントイネート、グリチルリチン酸塩、ヒノ
キチオール、クロルヘキシジン、リゾチーム、デ
キストラナーゼ、食塩、アズレン、ビタミンE等
を添加配合することができる。 In addition to the above-mentioned extract, any of the components normally used in oral compositions can be added to the oral composition of the present invention. These ingredients include, for example, in the case of toothpaste, abrasives such as dicalcium phosphate, calcium carbonate, aluminum hydroxide, amorphous silica, and crystalline silica; sodium carboxymethyl cellulose, carrageenan,
Binder such as hydroxyethylcellulose; surfactant such as sodium lauryl sulfate, sodium lauroyl sarcosinate, N-acylglutamate, sucrose fatty acid ester; wetting agent such as glycerin, sorbitol, propylene glycol. In addition, other medicinal agents can be used in combination, such as various fluorine compounds, aluminum allantoinate, glycyrrhizinate, hinokitiol, chlorhexidine, lysozyme, dextranase, salt, azulene, vitamin E, etc. Can be blended.
本発明の口腔用組成物は、例えば練歯磨、粉歯
磨、水歯磨、マウスウオツシユ、トローチ、パス
タ、塗布剤、歯肉マツサージクリーム、うがい用
錠剤、チユーインガム等に使用される。 The oral composition of the present invention can be used, for example, in toothpaste, powder toothpaste, water toothpaste, mouthwash, troche, pasta, liniment, gingival massage cream, gargling tablet, chewing gum, and the like.
次に実施例を挙げて本発明を説明する。 Next, the present invention will be explained with reference to Examples.
実施例 1
露蜂房(クロスズメバチの巣)の乾燥粉末100
gにエタノール350ml、水150mlを加え、これをマ
ントルヒーターで加熱し、冷却管を用いて3時間
還流した。次いで遠心分離により抽出エキスを分
離した。この抽出エキスを加熱濃縮し、エキス50
gを得た。次に該エキスを試験試料として使用
し、下記方法によりモルモツト下顎前歯部歯肉炎
に対する抗炎症作用を調べた。結果を第1図に示
す。Example 1 Dry powder of black wasp nest 100
350 ml of ethanol and 150 ml of water were added to the mixture, heated with a mantle heater, and refluxed for 3 hours using a cooling tube. The extract was then separated by centrifugation. Heat and concentrate this extracted extract, extract 50%
I got g. Next, the extract was used as a test sample to examine its anti-inflammatory effect on lower anterior gingivitis in guinea pigs by the method described below. The results are shown in Figure 1.
(試験方法)
実験動物としてハートレー系白色モルモツト
(体重400g、雌)を用い、1群8匹とし、これを
ネンブタールで麻酔した。次いで、がす針6号
10本の束により下顎前歯部に刺傷を作成した後、
1%n−酪酸ナトリウムで処置を行い起炎した。
起炎24時間後より経時的に、腫脹の程度を指標と
して、肉眼観察にて0〜3点の4段階に評点し、
腫脹度とした。(Test method) Hartley white guinea pigs (weight 400 g, female) were used as experimental animals, 8 animals per group, and anesthetized with Nembutal. Next, use a No. 6 gas needle
After creating a puncture wound in the mandibular anterior teeth with a bundle of 10,
Inflammation occurred after treatment with 1% sodium n-butyrate.
From 24 hours after the onset of inflammation, the degree of swelling is evaluated with the naked eye on a 4-point scale from 0 to 3.
It was defined as the degree of swelling.
試験試料は、界面活性剤と香料を含有しない歯
磨に、該エキスを1.0%(重量%)含有するよう
に添加したものを、1日1回20分間ネンブタール
麻酔下に炎症部位に投与し、24時間毎に腫脹の
程度をチエツクした。対照としてはエキスを含ま
ない歯磨を用いた。 The test sample was prepared by adding 1.0% (wt%) of the extract to toothpaste that did not contain surfactants or fragrances, and administering it to the inflamed area under Nembutal anesthesia for 20 minutes once a day. The degree of swelling was checked hourly. A toothpaste containing no extract was used as a control.
(評価基準)
0:腫脹は全く認められない
1:かすかに腫脹が認められる
2:中度の腫脹が認められる
3:高度の腫脹が認められる
第1図から明らかなように、露蜂房(クロスズ
メバチの巣)の抽出物が炎症を効果的に抑制する
ことが判明した。(Evaluation criteria) 0: No swelling observed 1: Slight swelling observed 2: Moderate swelling observed 3: Severe swelling observed As is clear from Figure 1, the It was found that the extract of wasp's nest (wasp's nest) effectively suppresses inflammation.
実施例 2 練歯磨 組成: リン酸水素カルシウム 49.0% カラギーナン 1.4 グリセリン 20.0 サツカリンナトリウム 0.1 露蜂房エキス(実施例1) 1.0 ラウリル硫酸ナトリウム 1.0 安息香酸ナトリウム 0.3 香 料 0.8 水 残量 100.0% 実施例 3 練歯磨 組成: 炭酸カルシウム 45.0% カルボキシメチルセルロース 1.2 ソルビツト 20.0 プロピレングリコール 4.0 サツカリンナトリウム 0.1 露蜂房エキス(実施例1) 0.5 ラウリル硫酸ナトリウム 1.2 安息香酸ナトリウム 0.3 香 料 0.8 水 残量 100.0% 実施例 4 練歯磨 組成: 無水ケイ酸 27.0% グリセリン 15.0 ソルビツト 40.0 カルボキシメチルセルロース 1.0 サツカリンナトリウム 0.2 露蜂房エキス(実施例1) 2.0 ラウリル硫酸ナトリウム 1.5 パラオキシ安息香酸メチル 0.2 香 料 0.8 水 残量 100.0% 実施例 5 マウスウオツシユ 組成: エタノール 15.0% サツカリンナトリウム 0.03 ラウリルジエタノールアミド 0.4 露蜂房エキス(実施例1) 1.0 香 料 0.8 水 残量 100.0% 実施例 6 歯肉マツサージクリーム 組成: 白色ワセリン 9.0% プロピレングリコール 4.0 ステアリルアルコール 7.5 ポリエチレングリコール4000 25.0 ポリエチレングリコール400 35.0 シヨ糖ステアリン酸エステル 0.5 露蜂房エキス(実施例1) 1.5 水 残量 100.0%Example 2 toothpaste composition: Calcium hydrogen phosphate 49.0% carrageenan 1.4 Glycerin 20.0 Satucalin sodium 0.1 Dew bee extract (Example 1) 1.0 Sodium lauryl sulfate 1.0 Sodium benzoate 0.3 Fragrance 0.8 Water remaining amount 100.0% Example 3 toothpaste composition: Calcium carbonate 45.0% Carboxymethylcellulose 1.2 Sorbittu 20.0 Propylene glycol 4.0 Satucalin sodium 0.1 Dew bee extract (Example 1) 0.5 Sodium lauryl sulfate 1.2 Sodium benzoate 0.3 Fragrance 0.8 Water remaining amount 100.0% Example 4 toothpaste composition: Silicic anhydride 27.0% Glycerin 15.0 Sorbittu 40.0 Carboxymethylcellulose 1.0 Satucalin sodium 0.2 Dew bee extract (Example 1) 2.0 Sodium lauryl sulfate 1.5 Methyl paraoxybenzoate 0.2 Fragrance 0.8 Water remaining amount 100.0% Example 5 mouthwash composition: Ethanol 15.0% Satucalin sodium 0.03 Lauryl diethanolamide 0.4 Dew bee extract (Example 1) 1.0 Fragrance 0.8 Water remaining amount 100.0% Example 6 Gum pine surge cream composition: White petrolatum 9.0% Propylene glycol 4.0 Stearyl alcohol 7.5 Polyethylene glycol 4000 25.0 Polyethylene glycol 400 35.0 Sucrose stearate 0.5 Dew beehive extract (Example 1) 1.5 Water remaining amount 100.0%
第1図は腫脹度の経時変化を示す。 Figure 1 shows the change over time in the degree of swelling.
Claims (1)
チの蜂の巣(露蜂房)の抽出物を含有することを
特徴とする口腔用組成物。 2 抽出物が水−エタノール混合溶媒により抽出
されたものである特許請求の範囲第1項記載の口
腔用組成物。 3 抽出物を全組成物に対して0.01〜5重量%含
有するものである特許請求の範囲第1項又は第2
項記載の口腔用組成物。[Scope of Claims] 1. An oral composition characterized by containing an extract of a honeycomb (dew bee cluster) of a paper wasp, a wasp, or a wasp. 2. The oral composition according to claim 1, wherein the extract is extracted with a water-ethanol mixed solvent. 3. Claim 1 or 2, which contains the extract in an amount of 0.01 to 5% by weight based on the total composition.
Oral composition as described in .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21564683A JPS60109516A (en) | 1983-11-16 | 1983-11-16 | Composition for oral cavity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21564683A JPS60109516A (en) | 1983-11-16 | 1983-11-16 | Composition for oral cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS60109516A JPS60109516A (en) | 1985-06-15 |
JPH0419206B2 true JPH0419206B2 (en) | 1992-03-30 |
Family
ID=16675847
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP21564683A Granted JPS60109516A (en) | 1983-11-16 | 1983-11-16 | Composition for oral cavity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60109516A (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62210952A (en) * | 1986-03-11 | 1987-09-17 | Kanebo Foods Ltd | Propolis-containing cake |
EP0422803A3 (en) * | 1989-10-11 | 1991-06-05 | Beecham Group p.l.c. | Dentifrice comprising cationic antibacterial agent |
JP4721630B2 (en) * | 2003-09-30 | 2011-07-13 | サンスター株式会社 | Anti-endotoxin agent and composition for oral cavity containing periodontal disease containing the same |
US8551457B2 (en) | 2008-11-25 | 2013-10-08 | The Procter & Gamble Company | Oral care compositions comprising spherical fused silica |
JP5717644B2 (en) | 2008-11-25 | 2015-05-13 | ザ プロクター アンド ギャンブルカンパニー | Oral care composition having improved aesthetics and fused silica |
AU2013337356B2 (en) | 2012-11-05 | 2016-12-08 | The Procter & Gamble Company | Heat treated precipitated silica |
-
1983
- 1983-11-16 JP JP21564683A patent/JPS60109516A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS60109516A (en) | 1985-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4272512A (en) | Antigingivitis composition | |
US20070098650A1 (en) | Dental formulation | |
JPH02229107A (en) | Composition for prevention and medical treatment of periodontosis | |
US4853213A (en) | Use of periwinkle in oral hygiene | |
JPS6234006B2 (en) | ||
JP3884808B2 (en) | Oral composition | |
JPS647964B2 (en) | ||
JPH0419206B2 (en) | ||
JPH0458447B2 (en) | ||
KR100537834B1 (en) | Oral Compositions against Halitosis | |
JPH0366283B2 (en) | ||
JP3008525B2 (en) | Oral composition | |
JP2001089385A (en) | Anti-dental caries agent | |
JPH0369883B2 (en) | ||
JPS5855409A (en) | Medicinal composition for preventing and treating periodontoses | |
JP2603465B2 (en) | Oral composition | |
JPH1087502A (en) | Composition for oral cavity | |
KR20010001476A (en) | Oral anti-halitosis preparations | |
JPS6258329B2 (en) | ||
JPH07309733A (en) | Composition for oral cavity | |
JPS60169413A (en) | Hygienic composition of oral cavity | |
JP2001089345A (en) | Anti-dental caries agent | |
JP2006022054A (en) | Composition for oral cavity | |
JPH10306019A (en) | Oral composition | |
JPS58134012A (en) | Composition for oral cavity application |